In October this year, Calderdale and Huddersfield NHS Foundation Trust, one of the first hospitals in England to trial BPMpathway, were named Overall Winners at the 2019 HTN Awards for ‘Digital Day Case Knee Pathway’ which also won the Most Promising Pilot award.
BPMpathway is a key element of their knee pathway and we are delighted that it has met with such resounding success among surgeons, staff and patients alike.
‘Education and communication between everyone is the key to our success. Patients feel they have more ownership of their health and care, for the pathway to be thrive they need to be as committed as the hospital team. This is the way to go. It is better for them and we’re reducing our lengths of stay too, without compromising patient care or outcomes.’
In an article in the Yorkshire Post in August 2019 titled ‘Pioneering Patient Physio App Piloted At Calderdale Hospital’, Mr. Graham Walsh, Consultant Orthopaedic Surgeon said:
‘The new [BPMpathway] app will not only speed up the patients’ recovery time and reduce waiting lists, but it will also save money. The app enables patients to reduce their stay in hospital for several days and they don’t require multiple physio appointments.’
Jacqui Potter, one of the first patients to test the device following knee surgery at Calderdale Hospital, said:
‘The [BPMpro] sensor kept me motivated each day to do my exercises, it’s easy to download via the App Store on my iPhone, and having the sensor made me do my exercises daily because I knew the physios were watching me. It was very easy to attach and use unattended.’
Following on from their triumph at the HTN Awards, Calderdale and Huddersfield FT are also finalists in the Digitising Patient Services Initiative category at the 2019 HSJ Awards with Digital Day Case Knee Pathway. The HSJ Awards, which are due to be announced in November, have been celebrating healthcare excellence for 39 years through huge political, technological and financial challenges within the sector.
As David Oates, Group Managing Director of the B. Braun companies in the UK, said:
‘It’s an incredibly exciting new product which benefits both clinicians and patients in equal measure.’
To read the full Yorkshire Post article, please click here.